Fig. 3

Evaluation of MRS in the discovery and validation cohorts [27]. A The AUC values and 95% confidence intervals (CIs) for MRSαs to predict healthy and different disease conditions in discovery and validation cohorts, respectively. B Venn diagrams of taxa identified in pairwise comparisons of healthy versus CA, CC, CD, and RA. CA, colorectal adenoma; CC, colorectal cancer; CD, Crohn’s disease; and RA, rheumatoid arthritis